Semaglutide

Last updated on: 13.03.2025

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Semaglutide s.c. (^Ozempic®) (1 x weekly)

GLP-1 receptor agonist for the treatment of inadequately controlled type 2 DM as an adjunctive therapy to dietary changes and more exercise, possibly in addition to metformin or other antidiabetic drugs (adults)

Semaglutide s.c. (^Wegovy®) (1 x weekly)

for weight reduction as an accompanying therapy to dietary changes and more exercise. (adults, children and adolescents aged 12 and over).

Semaglutide oral (^Rybelsus®) (Approved, but not yet on the market in Germany, as of 2/2025)

see GLP-1 receptor agonist

Last updated on: 13.03.2025